AG˹ٷ

STOCK TITAN

[8-K] Soleno Therapeutics, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

ChipMOS Technologies Inc. (Nasdaq: IMOS) filed a Form 6-K disclosing unaudited revenue for June 2025 and the second quarter ended 30 June 2025. Revenue momentum improved sequentially but remains slightly below prior-year levels.

  • 2Q25 revenue: NT$5,735.8 million (US$196.6 million), +3.7 % QoQ and -1.3 % YoY.
  • June 2025 revenue: NT$1,849.7 million (US$63.4 million), -8.7 % MoM and -3.5 % YoY.

Management attributes the sequential uptick to stronger customer demand and higher market pricing for memory products—core segments within the Company’s outsourced semiconductor assembly and test (OSAT) portfolio. Nonetheless, the monthly decline reflects typical seasonality and softer order timing.

ChipMOS is monitoring potential tariff developments that could affect customers shipping to the U.S. Although no material impact was recorded in 2Q25, any escalation could pressure demand going forward.

With three advanced facilities across Taiwan, ChipMOS serves fabless, IDMs, and foundries worldwide. No changes to guidance, earnings, or capital allocation were included in the filing.

ChipMOS Technologies Inc. (Nasdaq: IMOS) ha presentato un modulo 6-K con i ricavi non revisionati di giugno 2025 e del secondo trimestre terminato il 30 giugno 2025. La dinamica dei ricavi è migliorata sequenzialmente ma rimane leggermente inferiore ai livelli dell'anno precedente.

  • Ricavi 2T25: NT$5.735,8 milioni (US$196,6 milioni), +3,7% trimestre su trimestre e -1,3% anno su anno.
  • Ricavi giugno 2025: NT$1.849,7 milioni (US$63,4 milioni), -8,7% mese su mese e -3,5% anno su anno.

La direzione attribuisce l'aumento sequenziale a una domanda clienti più forte e a prezzi di mercato più elevati per i prodotti di memoria, segmenti chiave nel portafoglio OSAT (outsourced semiconductor assembly and test) dell’azienda. Tuttavia, il calo mensile riflette la stagionalità tipica e un calendario degli ordini meno favorevole.

ChipMOS sta monitorando potenziali sviluppi tariffari che potrebbero influenzare i clienti che spediscono verso gli Stati Uniti. Sebbene nel 2T25 non si siano registrati impatti significativi, un’escalation potrebbe mettere sotto pressione la domanda in futuro.

Con tre stabilimenti avanzati a Taiwan, ChipMOS serve fabless, IDM e fonderie a livello globale. Nel documento non sono state apportate modifiche alle previsioni, agli utili o all’allocazione del capitale.

ChipMOS Technologies Inc. (Nasdaq: IMOS) presentó un Formulario 6-K divulgando ingresos no auditados para junio de 2025 y el segundo trimestre terminado el 30 de junio de 2025. El impulso de los ingresos mejoró secuencialmente pero sigue ligeramente por debajo de los niveles del año anterior.

  • Ingresos 2T25: NT$5,735.8 millones (US$196.6 millones), +3.7% trimestral y -1.3% interanual.
  • Ingresos junio 2025: NT$1,849.7 millones (US$63.4 millones), -8.7% mensual y -3.5% interanual.

La dirección atribuye el aumento secuencial a una mayor demanda de clientes y a precios de mercado más altos para productos de memoria, segmentos centrales dentro de la cartera OSAT (ensamblaje y prueba de semiconductores externalizados) de la compañía. No obstante, la caída mensual refleja la estacionalidad típica y un calendario de pedidos más suave.

ChipMOS está monitoreando posibles desarrollos arancelarios que podrían afectar a clientes que envían a EE.UU. Aunque en el 2T25 no se registró un impacto material, cualquier escalada podría presionar la demanda en el futuro.

Con tres instalaciones avanzadas en Taiwán, ChipMOS atiende a empresas fabless, IDM y fundiciones en todo el mundo. No se incluyeron cambios en las previsiones, ganancias o asignación de capital en el informe.

ChipMOS Technologies Inc. (Nasdaq: IMOS)� 2025� 6� � 2025� 6� 30� 종료� 2분기 미감� 매출� 공개하는 Form 6-K� 제출했습니다. 매출 모멘텀은 분기별로 개선되었으나 전년 대� 약간 낮은 수준� 유지하고 있습니다.

  • 2분기 2025 매출: NT$57�3,580� (미화 1�9,660� 달러), 전분� 대� +3.7%, 전년 동기 대� -1.3%.
  • 2025� 6� 매출: NT$18�4,970� (미화 6,340� 달러), 전월 대� -8.7%, 전년 동월 대� -3.5%.

경영진은 분기� 매출 증가� 고객 수요 강세와 메모� 제품 시장 가� 상승 때문으로 보고 있습니다. � 제품들은 회사� OSAT(위탁 반도� 조립 � 테스�) 포트폴리오의 핵심 부문입니다. 다만 월간 매출 감소� 계절� 요인� 주문 시점 약화� 따른 것으� 설명됩니�.

ChipMOS� 미국으로 출하하는 고객에게 영향� 미칠 � 있는 잠재� 관� 동향� 주시하고 있습니다. 2분기에는 � 영향� 없었으나, 관세가 강화� 경우 향후 수요� 부담이 � � 있습니다.

대만에 위치� � 곳의 첨단 시설� 보유� ChipMOS� � 세계� 팹리�, IDM � 파운드리� 대상으� 서비스를 제공합니�. 제출� 자료에는 가이던�, 수익 또는 자본 배분� 대� 변� 사항� 포함되지 않았습니�.

ChipMOS Technologies Inc. (Nasdaq : IMOS) a déposé un formulaire 6-K divulguant les revenus non audités pour juin 2025 et le deuxième trimestre clos le 30 juin 2025. Le dynamisme des revenus s'est amélioré séquentiellement mais reste légèrement inférieur aux niveaux de l'année précédente.

  • Revenus 2T25 : 5 735,8 millions NT$ (196,6 millions USD), +3,7 % trimestre sur trimestre et -1,3 % en glissement annuel.
  • Revenus juin 2025 : 1 849,7 millions NT$ (63,4 millions USD), -8,7 % mois sur mois et -3,5 % en glissement annuel.

La direction attribue cette hausse séquentielle à une demande client plus forte et à des prix de marché plus élevés pour les produits mémoire, segments clés du portefeuille OSAT (outsourcing de l’assemblage et test de semiconducteurs) de la société. Néanmoins, la baisse mensuelle reflète la saisonnalité habituelle et un calendrier de commandes plus léger.

ChipMOS surveille les éventuels développements tarifaires susceptibles d’affecter les clients expédiant vers les États-Unis. Bien qu’aucun impact significatif n’ait été constaté au 2T25, toute escalade pourrait peser sur la demande à l’avenir.

Avec trois installations avancées à Taïwan, ChipMOS dessert des entreprises fabless, IDM et fonderies dans le monde entier. Aucun changement aux prévisions, aux résultats ou à l’allocation du capital n’a été inclus dans le dépôt.

ChipMOS Technologies Inc. (Nasdaq: IMOS) hat ein Formular 6-K eingereicht, in dem ungeprüfte Umsatzzahlen für Juni 2025 und das am 30. Juni 2025 endende zweite Quartal offengelegt werden. Die Umsatzdynamik verbesserte sich sequenziell, liegt jedoch leicht unter dem Vorjahresniveau.

  • Umsatz 2Q25: NT$5.735,8 Millionen (US$196,6 Millionen), +3,7 % Quartal über Quartal und -1,3 % Jahr über Jahr.
  • Umsatz Juni 2025: NT$1.849,7 Millionen (US$63,4 Millionen), -8,7 % Monat über Monat und -3,5 % Jahr über Jahr.

Das Management führt den sequenziellen Anstieg auf eine stärkere Kundennachfrage und höhere Marktpreise für Speicherprodukte zurück � Kernsegmente im OSAT-Portfolio (Outsourced Semiconductor Assembly and Test) des Unternehmens. Dennoch spiegelt der monatliche Rückgang die übliche Saisonalität und eine schwächere Auftragslage wider.

ChipMOS beobachtet potenzielle Zollentwicklungen, die Kunden betreffen könnten, die in die USA liefern. Obwohl im 2Q25 keine wesentlichen Auswirkungen zu verzeichnen waren, könnte eine Eskalation die Nachfrage künftig belasten.

Mit drei hochmodernen Einrichtungen in Taiwan bedient ChipMOS weltweit Fabless-Unternehmen, IDMs und Foundries. Im Bericht wurden keine Änderungen an den Prognosen, Gewinnen oder Kapitalallokationen vorgenommen.

Positive
  • Quarterly revenue rose 3.7 % QoQ, indicating sequential demand recovery and improved memory pricing.
  • Management cites stronger customer demand as a driver, a constructive sign for 2H25 utilization.
Negative
  • June revenue fell 8.7 % MoM and 3.5 % YoY, suggesting lingering volatility.
  • Tariff uncertainty could dampen future demand, though not yet material.

Insights

TL;DR: Sequential revenue growth signals early memory recovery, but YoY contraction and tariff risk temper enthusiasm; overall impact modestly positive.

2Q25 sales exceeded 1Q25 by 3.7 %, confirming incremental improvement in DRAM/NAND pricing that many peers have cited. While the YoY decline is minimal, it shows the rebound is not yet complete. Given ChipMOS’s high memory mix, the uplift is encouraging for gross-margin trajectory, though we need margin disclosure to quantify. June’s 8.7 % pullback is typical post-rush seasonality and does not invalidate the quarterly uptrend. Tariff vigilance is prudent; historical U.S. exposure is <20 % of revenue, limiting immediate downside. Overall, the update is mildly constructive but not a game-changer for valuation.

TL;DR: Revenue data neutral, but disclosed tariff monitoring highlights lingering geopolitical risk; investors should keep watch yet remain calm.

ChipMOS acknowledges that evolving U.S. tariff policy could dent customer demand. Although immaterial this quarter, the statement implies contingency planning. For an OSAT vendor, geographic diversification of customer fabs and final markets mitigates concentrated exposure. Still, any broad tariff expansion on Chinese-sourced components could limit upside. From a risk lens, disclosure is appropriate but does not raise immediate red flags.

ChipMOS Technologies Inc. (Nasdaq: IMOS) ha presentato un modulo 6-K con i ricavi non revisionati di giugno 2025 e del secondo trimestre terminato il 30 giugno 2025. La dinamica dei ricavi è migliorata sequenzialmente ma rimane leggermente inferiore ai livelli dell'anno precedente.

  • Ricavi 2T25: NT$5.735,8 milioni (US$196,6 milioni), +3,7% trimestre su trimestre e -1,3% anno su anno.
  • Ricavi giugno 2025: NT$1.849,7 milioni (US$63,4 milioni), -8,7% mese su mese e -3,5% anno su anno.

La direzione attribuisce l'aumento sequenziale a una domanda clienti più forte e a prezzi di mercato più elevati per i prodotti di memoria, segmenti chiave nel portafoglio OSAT (outsourced semiconductor assembly and test) dell’azienda. Tuttavia, il calo mensile riflette la stagionalità tipica e un calendario degli ordini meno favorevole.

ChipMOS sta monitorando potenziali sviluppi tariffari che potrebbero influenzare i clienti che spediscono verso gli Stati Uniti. Sebbene nel 2T25 non si siano registrati impatti significativi, un’escalation potrebbe mettere sotto pressione la domanda in futuro.

Con tre stabilimenti avanzati a Taiwan, ChipMOS serve fabless, IDM e fonderie a livello globale. Nel documento non sono state apportate modifiche alle previsioni, agli utili o all’allocazione del capitale.

ChipMOS Technologies Inc. (Nasdaq: IMOS) presentó un Formulario 6-K divulgando ingresos no auditados para junio de 2025 y el segundo trimestre terminado el 30 de junio de 2025. El impulso de los ingresos mejoró secuencialmente pero sigue ligeramente por debajo de los niveles del año anterior.

  • Ingresos 2T25: NT$5,735.8 millones (US$196.6 millones), +3.7% trimestral y -1.3% interanual.
  • Ingresos junio 2025: NT$1,849.7 millones (US$63.4 millones), -8.7% mensual y -3.5% interanual.

La dirección atribuye el aumento secuencial a una mayor demanda de clientes y a precios de mercado más altos para productos de memoria, segmentos centrales dentro de la cartera OSAT (ensamblaje y prueba de semiconductores externalizados) de la compañía. No obstante, la caída mensual refleja la estacionalidad típica y un calendario de pedidos más suave.

ChipMOS está monitoreando posibles desarrollos arancelarios que podrían afectar a clientes que envían a EE.UU. Aunque en el 2T25 no se registró un impacto material, cualquier escalada podría presionar la demanda en el futuro.

Con tres instalaciones avanzadas en Taiwán, ChipMOS atiende a empresas fabless, IDM y fundiciones en todo el mundo. No se incluyeron cambios en las previsiones, ganancias o asignación de capital en el informe.

ChipMOS Technologies Inc. (Nasdaq: IMOS)� 2025� 6� � 2025� 6� 30� 종료� 2분기 미감� 매출� 공개하는 Form 6-K� 제출했습니다. 매출 모멘텀은 분기별로 개선되었으나 전년 대� 약간 낮은 수준� 유지하고 있습니다.

  • 2분기 2025 매출: NT$57�3,580� (미화 1�9,660� 달러), 전분� 대� +3.7%, 전년 동기 대� -1.3%.
  • 2025� 6� 매출: NT$18�4,970� (미화 6,340� 달러), 전월 대� -8.7%, 전년 동월 대� -3.5%.

경영진은 분기� 매출 증가� 고객 수요 강세와 메모� 제품 시장 가� 상승 때문으로 보고 있습니다. � 제품들은 회사� OSAT(위탁 반도� 조립 � 테스�) 포트폴리오의 핵심 부문입니다. 다만 월간 매출 감소� 계절� 요인� 주문 시점 약화� 따른 것으� 설명됩니�.

ChipMOS� 미국으로 출하하는 고객에게 영향� 미칠 � 있는 잠재� 관� 동향� 주시하고 있습니다. 2분기에는 � 영향� 없었으나, 관세가 강화� 경우 향후 수요� 부담이 � � 있습니다.

대만에 위치� � 곳의 첨단 시설� 보유� ChipMOS� � 세계� 팹리�, IDM � 파운드리� 대상으� 서비스를 제공합니�. 제출� 자료에는 가이던�, 수익 또는 자본 배분� 대� 변� 사항� 포함되지 않았습니�.

ChipMOS Technologies Inc. (Nasdaq : IMOS) a déposé un formulaire 6-K divulguant les revenus non audités pour juin 2025 et le deuxième trimestre clos le 30 juin 2025. Le dynamisme des revenus s'est amélioré séquentiellement mais reste légèrement inférieur aux niveaux de l'année précédente.

  • Revenus 2T25 : 5 735,8 millions NT$ (196,6 millions USD), +3,7 % trimestre sur trimestre et -1,3 % en glissement annuel.
  • Revenus juin 2025 : 1 849,7 millions NT$ (63,4 millions USD), -8,7 % mois sur mois et -3,5 % en glissement annuel.

La direction attribue cette hausse séquentielle à une demande client plus forte et à des prix de marché plus élevés pour les produits mémoire, segments clés du portefeuille OSAT (outsourcing de l’assemblage et test de semiconducteurs) de la société. Néanmoins, la baisse mensuelle reflète la saisonnalité habituelle et un calendrier de commandes plus léger.

ChipMOS surveille les éventuels développements tarifaires susceptibles d’affecter les clients expédiant vers les États-Unis. Bien qu’aucun impact significatif n’ait été constaté au 2T25, toute escalade pourrait peser sur la demande à l’avenir.

Avec trois installations avancées à Taïwan, ChipMOS dessert des entreprises fabless, IDM et fonderies dans le monde entier. Aucun changement aux prévisions, aux résultats ou à l’allocation du capital n’a été inclus dans le dépôt.

ChipMOS Technologies Inc. (Nasdaq: IMOS) hat ein Formular 6-K eingereicht, in dem ungeprüfte Umsatzzahlen für Juni 2025 und das am 30. Juni 2025 endende zweite Quartal offengelegt werden. Die Umsatzdynamik verbesserte sich sequenziell, liegt jedoch leicht unter dem Vorjahresniveau.

  • Umsatz 2Q25: NT$5.735,8 Millionen (US$196,6 Millionen), +3,7 % Quartal über Quartal und -1,3 % Jahr über Jahr.
  • Umsatz Juni 2025: NT$1.849,7 Millionen (US$63,4 Millionen), -8,7 % Monat über Monat und -3,5 % Jahr über Jahr.

Das Management führt den sequenziellen Anstieg auf eine stärkere Kundennachfrage und höhere Marktpreise für Speicherprodukte zurück � Kernsegmente im OSAT-Portfolio (Outsourced Semiconductor Assembly and Test) des Unternehmens. Dennoch spiegelt der monatliche Rückgang die übliche Saisonalität und eine schwächere Auftragslage wider.

ChipMOS beobachtet potenzielle Zollentwicklungen, die Kunden betreffen könnten, die in die USA liefern. Obwohl im 2Q25 keine wesentlichen Auswirkungen zu verzeichnen waren, könnte eine Eskalation die Nachfrage künftig belasten.

Mit drei hochmodernen Einrichtungen in Taiwan bedient ChipMOS weltweit Fabless-Unternehmen, IDMs und Foundries. Im Bericht wurden keine Änderungen an den Prognosen, Gewinnen oder Kapitalallokationen vorgenommen.

SOLENO THERAPEUTICS INC false 0001484565 0001484565 2025-07-10 2025-07-10
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): July 10, 2025

 

 

SOLENO THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-36593   77-0523891

(State or other jurisdiction

of incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification Number)

100 Marine Parkway, Suite 400

Redwood City, CA 94065

(Address of principal executive offices)

(650) 213-8444

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

symbols

 

Name of each exchange

on which registered

Common Stock, $0.001 par value   SLNO   NASDAQ

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 2.02.

Results of Operations and Financial Conditions

On July 10, 2025, Soleno Therapeutics, Inc. (the “Company”) issued a press release to announce certain preliminary financial results and operating metrics for the three months ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

The information furnished pursuant to Item 2.02 (including Exhibit 99.1) on this Form 8-K, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01

Financial Statements and Exhibits.

 

(d)

Exhibits.

 

Exhibit No.

  

Description

99.1    Press Release issued by Soleno Therapeutics, Inc., dated July 10, 2025
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    SOLENO THERAPEUTICS, INC.
Date: July 10, 2025     By:  

/s/ Anish Bhatnagar

      Anish Bhatnagar
      Chief Executive Officer

FAQ

How did ChipMOS (IMOS) perform in 2Q25?

ChipMOS reported NT$5.736 billion (US$196.6 m) revenue, up 3.7 % QoQ and down 1.3 % YoY.

What were ChipMOS’s June 2025 sales?

June revenue was NT$1.850 billion (US$63.4 m), a -8.7 % MoM and -3.5 % YoY change.

Why did revenue improve quarter-over-quarter?

Management cited increased customer demand and higher memory product pricing as primary drivers.

Is ChipMOS affected by U.S. tariffs?

The company says tariffs were not material in 2Q25 but is monitoring developments and will adapt to support customers.

Did the filing include profit or margin figures?

No, the 6-K only provided unaudited revenue data; no earnings or margin details were disclosed.
Soleno Therapeutics Inc

NASDAQ:SLNO

SLNO Rankings

SLNO Latest News

SLNO Latest SEC Filings

SLNO Stock Data

4.34B
47.40M
2.93%
113.72%
10.48%
Biotechnology
Electromedical & Electrotherapeutic Apparatus
United States
REDWOOD CITY